课题基金 / 基金详情

TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN

TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
绝经后女性手术后的睾酮剂量反应
批准号:
7720968
负责人:
Matthew H. Ho
金额:
$1.92万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2009-08-31

项目摘要

项目成果

Matthew H. Ho的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 具体目标: 1.本研究的主要目标是在外科手术中建立睾酮剂量-反应关系。 睾酮浓度低的更年期妇女对一系列雄激素依赖的结果有影响, 包括性功能、脱脂体重、大腿肌肉力量和腿部力量,几个领域 神经认知功能,血脂,载脂蛋白和脂蛋白颗粒,以及胰岛素敏感性。 2.次要目标是确定睾丸素的剂量范围和随后的血浆 与性、生理和神经认知改善相关的睾酮浓度 而且可以安全地给妇女服用,不会产生严重的不良影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific Aims: 1. Primary objective of this study is to establish testosterone dose-response relationships in surgically menopausal women with low testosterone concentrations for a range of androgen-dependent outcomes, including sexual function, fat-free mass, thigh muscle strength and leg power, several domains of neurocognitive function, plasma lipids, apolipoproteins and lipoprotein particles, and insulin sensitivity. 2. The secondary objective is to determine the range of testosterone doses and subsequent plasma testosterone concentrations that are associated with improvements in sexual, physical and neurocognitive functions and that can be safely administered to women without significant adverse effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
CLINICAL TRIAL: TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
Regeneration of the Pelvic and Urethral Supports by Muscle Derived Stem Cells
海外基金